Open Access

Increasing on-target cleavage efficiency for CRISPR/Cas9-induced large fragment deletion in Myxococcus xanthus

Microbial Cell Factories201716:142

https://doi.org/10.1186/s12934-017-0758-x

Received: 17 May 2017

Accepted: 9 August 2017

Published: 16 August 2017

Abstract

Background

The CRISPR/Cas9 system is a powerful tool for genome editing, in which the sgRNA binds and guides the Cas9 protein for the sequence-specific cleavage. The protocol is employable in different organisms, but is often limited by cell damage due to the endonuclease activity of the introduced Cas9 and the potential off-target DNA cleavage from incorrect guide by the 20 nt spacer.

Results

In this study, after resolving some critical limits, we have established an efficient CRISPR/Cas9 system for the deletion of large genome fragments related to the biosynthesis of secondary metabolites in Myxococcus xanthus cells. We revealed that the high expression of a codon-optimized cas9 gene in M. xanthus was cytotoxic, and developed a temporally high expression strategy to reduce the cell damage from high expressions of Cas9. We optimized the deletion protocol by using the tRNA–sgRNA–tRNA chimeric structure to ensure correct sgRNA sequence. We found that, in addition to the position-dependent nucleotide preference, the free energy of a 20 nt spacer was a key factor for the deletion efficiency.

Conclusions

By using the developed protocol, we achieved the CRISPR/Cas9-induced deletion of large biosynthetic gene clusters for secondary metabolites in M. xanthus DK1622 and its epothilone-producing mutant. The findings and the proposals described in this paper were suggested to be workable in other organisms, for example, other Gram negative bacteria with high GC content.

Keywords

CRISPR/Cas9 On-target cleavage efficiency Spacer sequence Free energy Deletion of large genome fragments Biosynthetic gene clusters for secondary metabolites Epothilones Myxococcus xanthus

Background

Clustered regularly interspaced short palindromic repeats (CRISPRs) play functions in prokaryotes as an acquired immune system, conferring host cells the resistance to exogenous genetic elements such as plasmids and phages [13]. Among the known CRISPR systems, the type II system utilizes a single CRISPR-associated (Cas) endonuclease protein, such as Cas9 from Streptococcus thermophiles [4], for sequence-directed DNA cleavage, guided by the CRISPR associated RNA (crRNA) for DNA targeting. The trans-activating RNA (tracrRNA) is a non-coding RNA that is able to form a RNA duplex with pre-crRNA for nuclease activity [5]. The two RNAs can be fused into a chimeric single guide RNA (sgRNA), which allows convenient and efficient delivery of the whole system for DNA cleavage targeting at the sequence containing a 20 nt protospacer and the NGG protospacer-adjacent motif (PAM) (5′-N20-NGG-3′; N indicates any base) [6]. The 20 nt guide RNA sequence can be easily replaced to retarget the Cas9 nuclease to a gene of choice. In recent years, the CRISPR/Cas9 system has been developed into a powerful genome-editing tool employable in different eukaryotes [712]. This genetic tool has also been harnessed for genome editing in bacterial species, including Escherichia coli [13], Bacillus [14], Corynebacterium [15], Clostridium [16, 17], Lactobacillus [18] and Streptomyces [1921]. There are two major questions to be resolved for efficient applications of the CRISPR/Cas9 system. One is cell damage due to the endonuclease activity of introduced Cas9. The other is potential off-target DNA cleavage produced from incorrect guide by a selected 20 nt sequence, on which there have been reported many results, but often with paradoxical conclusions, for example, effects of the GC content on sgRNA activity [22, 23], the hairpin structures in sgRNA [10, 22] or the gRNA sequence features [24, 25] on cleavage efficiency.

The Gram-negative myxobacteria belong to the delta division of the Proteobacteria, and are well known for their multicellular social behaviors and the production abilities of diverse secondary metabolites [2628]. The myxobacterial cells harbor large genomes [2932], containing lots of genes related to the complex sociality and the biosynthesis of diverse secondary metabolites. The Myxococcus xanthus DK1622 is a model strain of the myxobacteria and has been developed as an efficient host for the expression of secondary metabolites from other difficult-to-handle myxobacteria, such as epothilone, haliangicin, disorazol [3337]. The strain itself possesses 24 biosynthetic gene clusters for secondary metabolisms, occupying 8.6% of the 9.14-Mb circular genome, and is a potential producer of multiple secondary metabolites [38]. Up to now, six compounds (myxochelins, myxochromides, myxovirescin, DKxanthenes, myxalamids, and myxoprincomide) have been identified and correlated to their biosynthetic gene clusters in DK1622 [3942]. According to the transcriptomic and proteomic analyses, the remaining unassigned pathways are also active under standard cultivation conditions [43]. It is industrially interesting to remodel the large genome of this model myxobacterium to a ‘microbial factory’ [44] for the production of bioactive secondary metabolites, which, however, is limited by lacking efficient genome editing protocols.

In this study, we established an efficient CRISPR/Cas9 system for the deletion of large genome fragments in M. xanthus DK1622. We developed a strategy for temporally high expression of Cas9 to decrease the cytotoxicity of this endonuclease in M. xanthus. We used a tRNA–sgRNA–tRNA strategy to ensure the production of correct sgRNA molecules. We found that, in addition to the position-dependent nucleotide preference, the free energy of a 20 nt spacer was a key factor for the deletion efficiency. By using the developed process, we successfully deleted large biosynthetic gene clusters for the production of secondary metabolites in M. xanthus. We assayed the deletion effects on yields of other secondary metabolites, including the heterologous epothilones.

Results

M. xanthus cells cannot tolerate highly-expressed Cas9 endonuclease

The 35.1% GC-content of cas9 is greatly lower than that of the M. xanthus DK1622 genome (68.9%). To develop a CRISPR/Cas9 editing system in M. xanthus, we employed a codon-optimized cas9 gene, which had been used in similarly high-GC-possessing Streptomyces species [19]. Cas9 is an endonuclease. Introducing the Cas9-encoding gene into M. xanthus might lead to cytotoxicity. To determine influences of Cas9 in M. xanthus cells, we inserted a copper-inducible promoter (PcuoA) [45] in front of the cas9 gene to control its expression corresponding to the copper concentration. The tracrRNA and crRNA sequences were connected into a single sgRNA sequence (Additional file 1: Figure S1). The pET-based plasmids cannot replicate in Myxococcus xanthus cells. We constructed two pET-based suicide plasmids: pET28a–PcuoA-Cas9, which contains the cas9 gene under the control of copper-inducible promoter PcuoA, and pET28a–PcuoA-Cas9–sgRNA, which has an additional T7A1-controlled sgRNA containing a 20 nt spacer targeting the myxochelin gene cluster (Additional file 2: Figure S2). The two plasmids were both integrated into the genome of DK1622 by a single crossover at the 3976002..3976945 complementary sequence site with the 944-bp PcuoA promoter homologous arm, producing transformants DK-Cas9 and DK-Cas9–sgRNA, respectively, which were confirmed by PCR and sequencing.

The DK-Cas9 and DK-Cas9–sgRNA mutants showed almost the same growth abilities as the wild type DK1622 in liquid CTT medium without the addition of copper. When different concentrations of copper were added into the medium, the growth abilities of these two mutants both became greatly weakened (Fig. 1a demonstrates the OD600 values of these cultures after 24 h of incubation in CTT liquid medium supplemented with different concentrations of copper). At the 12.5 μM copper concentration or lower, the OD600 values of the DK-Cas9 and DK-Cas9–sgRNA cultures were similar to that observed in DK1622. With the increase of copper concentration, the growth of DK-Cas9–sgRNA sharply decreased, whereas the DK-Cas9 mutant still had almost the same growth ability as DK1622 and markedly decreased at 35 μM of the copper concentration. The DK-Cas9–sgRNA and DK-Cas9 mutants showed almost no growth at the 35- and 45-μM copper concentrations, respectively. As the wild type strain DK1622 is able to tolerate up to 500 μM copper concentration [45], the growth inhibition of the mutant cells was suggested to be due to the toxicity of highly expressed cas9 gene in M. xanthus cells, rather than the presence of copper in medium. We assayed the cas9 expression changes in DK1622-Cas9–sgRNA after treating the cells with different copper concentrations for 5 h. The result showed that the cas9 expressions were similar with low copper concentrations (≤30 μM), but greatly up-regulated at a higher copper concentration (40 μM) after additional 5-h incubation, then sharply decreased with the increase of incubation time (Fig. 1b). Thus, the introduced CRISPR/Cas9 system does not affect the growth of M. xanthus cells when the cas9 expression was kept at low concentrations. The different inhibition tolerances of the two mutants on copper concentration suggested that the cell damage from the directed DNA cleavage by the sgRNA–aided Cas9 was more serious than the potential random cleavage by Cas9 (without sgRNA activation).
Fig. 1

Effects of copper concentrations on the cellular growth of M. xanthus and the cas9 gene expressions. a The growth abilities of DK1622 and the DK-Cas9 and DK-Cas9–sgRNA mutants in CTT medium containing different concentrations of copper. The cas9 gene is controlled by the PcuoA promoter. Cells grown in the absence of copper were diluted to 0.05 OD600 value in the CTT medium containing the indicated copper concentration, which were then incubated at 30 °C for 24 h, and monitored the cell density. b Expressions of the cas9 gene in DK-Cas9–sgRNA induced with different copper concentrations. At 0 h, the cells were treated with different copper concentrations in CTT medium. After 5 h of incubation, the cells were harvested by centrifugation, and further incubated in CTT medium. The cas9 gene expressions in cell were assayed. Experiments were performed in triplicate

Deletion of the myxovirescin gene cluster from the M. xanthus DK1622 genome

Myxovirescin (TA) is a major kind of the secondary metabolites produced by M. xanthus DK1622, and the biosynthetic gene cluster is approximately 83 kb in size [38]. To delete the myxovirescin gene cluster, we employed the well-studied attB-site-specific integrating plasmid pSWU30 and suicide plasmid pBJ113 to integrate cas9–sgRNA and two homologous arms of the myxovirescin gene cluster into host chromosome, respectively (the process is demonstrated in Fig. 2). The spacer sequence is 11-2 (listed in Table 1), which is located in the downstream of the myxovirescin biosynthetic gene cluster. It was reported that inserting a tRNA sequence in front of sgRNA was able to improve the edition efficiency of the CRISPR/Cas9 system in plant cells [12]. We employed the strategy with a modification by adding a second tRNA gene following the sgRNA sequence, forming a tRNA–sgRNA–tRNA architecture to ensure the production of the sgRNA molecule (containing the 11-2 20-nt spacer and a 76-bp gRNA scaffold). The sgRNA expression cassette was approximately 400 bp, consisting of a promoter, a tRNA, a sgRNA, a second tRNA, and the terminator (details refer to Additional file 1: Figure S1, Additional file 2: Figure S2). The cas9 gene was firstly cloned into pET28a by a double digestion with XbaI + EcoRI. The gene was under the control of the highly-efficient constitutive promoter PpilA, which was also substituted to the copper-inducible promoter PcuoA (Fig. 3a). The sgRNA cassette was cloned into the intermediate plasmid by EcoRI + HindIII (Fig. 3b). The fragment containing the cas9 gene and the sgRNA cassette was then obtained by a double digestion with XbaI + HindIII, and transferred to pSWU30E to form the pSWU30EE-1 and pSWU30EE-2 plasmids (Additional file 3: Figure S3), respectively.
Fig. 2

The diagrammatic sketch describing the progresses for the genome edition. Firstly, the suicide plasmid pBJ113 was integrated into the genome by a single crossover of homologous recombination at one of the two homologous arms constructed in the pBJ113 plasmid, which were designed at the places flanking the target gene cluster. Secondly, a CRISPR/Cas9 editing plasmid pSWU30EE was transferred into M. xanthus genome by site-specific integration. The pSWU30EE plasmid contained an inducible promoter-driven cas9 gene and a constitutive promoter controlled sequence-specific sgRNA. Thirdly, the expressed Cas9 was guided by the sgRNA sequence to target at the complementary chromosomal site for cleaving, producing a double-strand break in the chromosome. The cleaved chromosome was repaired by the other homologous arm that was constructed in the pBJ113 plasmid in a homologous recombination repair mechanism. After a double crossover of homologous recombination, only the cells with the deletion of the target fragment were survived. According to the design, the recombination occurred at either of the two homologous arms, which had been constructed in the pBJ113 plasmid. During the deletion of the myxovirescin gene cluster in DK1622, we confirmed that integration of the pBJ113 plasmid into the genome of DK1622 occurred via the left arm by a single crossover of homologous recombination. After the integration of pSWU30EE and induction, the double-strand break was repaired by second crossover homologous recombination via the right homologous arm

Table 1

Information of the 5′-N20-NGG-3′ spacer candidates for the deletion of the biosynthetic gene clusters for myxovirescin and myxalamids

Namea

20 nt spacer sequenceb

Hairpin

GC (%)

ΔGc

11-1

TGCAAATCGGAGTAGAAGCG CGG

N

50

−39.6

11-2

GCCGACGCCGCCCTTGATGG TGG

N

75

−49.0

11-3

GCGTGAGGAGGAAGCGGCGG TGG

N

75

−47.3

11-4

TCCTGTCCGAACCGCCCGCC CGG

N

75

−48.4

17-4

GACGAGGCACCTAGAGACAC TGG

N

60

−35.8

17-5

CCACTCATCCAGGACGCTAC TGG

N

60

−37.8

17-6

CGCGAGGCTGCGGCTGCCAC TGG

Y

80

−49.3

17-7

GACGCCCCATCCCCAACCAC TGG

N

70

−44.7

17-8

CGAGAGGTCGCTCTCCAAAC TGG

Y

60

−39.3

17-9

GGCGATGATGAGGAACCAAC TGG

N

55

−39.2

17-10

CCTGCTCCTGCGCCTTCCAC TGG

N

70

−44.0

Degenerated

NVH-N2-BNH-N2-H-N5-HHAC TGG

   

aThe locations are referred to Fig. 4 for 11-1 to 11-4 and Fig. 5 for 17-4 to 17-10

bDisfavored nucleotides are shown in italics

cΔG indicates free energy (kcals/mol). The calculation of free energy and prediction of hairpin in 20 nt spacer were performed by primer premier 5.00

dH: A/T/C, V: G/A/C, B: G/T/C, N: any nucleotide; the C-terminus TGG or CGG is the PAM motif

Fig. 3

Vector design for Cas9/sgRNA mediated genome editing in M. xanthus. a The Cas9/sgRNA expression plasmids were constructed in vector pSWU30. The cas9 gene was promoted by the constitutive promoter (PpilA) or the copper-inducible promoter (PcuoA), and the tRNA–sgRNA–tRNA chimeric gene was transcribed from the T7A1 promoter or the PpilA promoter and terminated by T7 terminator. b Construction of sgRNA transcription cassette. The model cassette was artificially synthesized and cloned into pUC57. Two primers, general primer gRNA-F and custom primer SgXR, which contained specific 20 nt spacer, were used to produce new target site

The pSWU30EE-1 plasmid, in which the cas9 gene was driven by the constitutive promoter PpilA, produced no deletion mutant. This result was probably due to the lethality of high expressions of Cas9, which is consistent with the above results that the M. xanthus cells containing PcuoA-controlled cas9 gene were unable to grow with high copper concentrations (Fig. 1). In contrast, transformation of pSWU30EE-2 (containing the PcuoA-controlled cas9 gene) into the M. xanthus DK1622 produced kanamycin resistant colonies after the induction at the 25-μM copper concentration. Single colonies of the mutants were inoculated on CTT agar plate with or without kanamycin. From the total 30 colonies that appeared on the CTT plate without kanamycin, we obtained three strains, whose corresponding inoculates could not form colonies on the plate with kanamycin, suggesting they lost the kanamycin resistance. PCR amplification using the primers 8/6 annealing outside the 2 kb homology arms (Fig. 4a) produced the desired 3.5-kb band in these three Kan mutants, but none in the wild type strain (Fig. 4b), which suggested that the 83-kb myxovirescin gene cluster has been deleted in the three Kan mutants. The deletion was confirmed by sequencing (Fig. 4c). HPLC–MS assays also detected no myxovirescin in the mutant broth (Fig. 4d).
Fig. 4

Large fragment deletion of the myxovirescin biosynthetic gene cluster in M. xanthus DK1622. a Schematic diagram for the deletion program. Left and right homologous arms are shown in red and pink rectangles, respectively. Gray and green arrows represent galK gene and kanR gene, respectively. b Identification of mutant strains by agarose gel electrophoresis of PCR product. The PCR primers 8 and 6 (referred to the a) yielded the 3.5-kb positive band (indicated by blue arrow) in three independent mutants (lanes 1–3), but not in the negative controls of DK1622 (lane E) and DKpBJ11-tsg112 (lane D). c Chromatograms of the 3.5-kb PCR product DNA sequences, sequenced using the primers 8 and 6 as the sequencing primers. Since plasmid pBJ11 contains the nucleotide sequence crossing the deleted chromosomal region, we sequenced the flanked region at two ends of the 3.5-kb PCR product. d EIC of myxovirescin A ([M+H]+ m/z 624.44) from the DK1622 (blue) and mutant (red)

Temporally high expression of the cas9 gene improves the deletion efficiency

The above established CRISPR/Cas9 system was efficient in the deletion of the myxovirescin gene cluster in M. xanthus with an efficiency approaching 10% (3/30) of the bacterial population, but 100% of the three Kan mutants. Although the tRNA–sgRNA–tRNA strategy may improve the edition efficiency, the selected 20 nt spacer sequence was suggested to play a critical role for the on-target deletion efficiency. To evaluate effects of the 20 nt spacer, we further replaced the 11-2 spacer with 11-1, 11-3 or 11-4, which also flanked the myxovirescin gene cluster (Fig. 5a), to construct the series plasmids of pSWU30EE-2-11. These plasmids were transformed into the DK1622::pBJ-11 strain, which was used in the above construction process for the 11-2 spacer, forming series mutants. However, using the same cultivation and induction processes as mentioned above, we got no correct deletion strain with these three plasmids in screenings of approximately 200 colonies for each.
Fig. 5

Comparison of the cleavage efficiency of gene cluster guided by four spacers under different conditions. a Four spacer positions (11-1 to 11-4) flanking the myxovirescin gene cluster were used as the sgRNA-targeting sites for deletion. The genes involved in the biosynthesis of myxovirescin are shown in the arrows. The positions of the guide sequences are indicated. b Histograms show the target cleavage efficiencies of the four sgRNAs including the 11-1 to 11-4 spacers, respectively, controlled with different promoters or different concentrations of copper ion. Experiments were performed in triplicate. Error bars indicate standard deviations

It is known that loading sgRNA into the binding complex of Cas9 and double-strand DNA substrates containing PAM-region is a crucial step in converting Cas9 into an active conformation capable of executing its nuclease function [6]. Ren et al. reported that the concentration level of Cas9, within a tested wide range, was not a critical factor for mutagenesis efficiency, while the amount of introduced sgRNA had a more profound impact on the in vivo mutagenesis and cell growth in eukaryotic Drosophila [46]. To increase the concentration of sgRNA in cells, we used the Golden Gate assembly [47] to replace the sgRNA promoter PT7A1 (58-bp in length) with a more powerful promoter PpilA (167-bp in length) to produce the pUC-PXX series (Additional file 2: Figure S2), which were cloned into pSWU30E to form the pSWU30EE-3 plasmids containing the 11-1 to 11-4 spacers, respectively (Fig. 3a; Table 1). Similarly, we got no deletion mutant from the screening of approximately 100 colonies in each of the 11-1, -3 and -4 transformants. The result suggested that high levels of sgRNA were not critical to induce the production of DSB and recombination. Thus, within the tested range, the quantity of sgRNA was not a key factor influencing the sgRNA cleavage activity in the one-target CRISPR/cas9 experiment.

We further speculated that the quantity of Cas9 protein was probably an affecting factor for the genome edition in this high GC-content bacterium. As the DK1622 mutants integrated with the cas9 gene could not grow beyond the 50 μM copper concentration (Fig. 1), we attempted to cultivate the mutants at a high copper concentration within one generation time, namely, approximately 4 h of incubation. The protocol was suggested to be able to obtain temporal high expressions of the Cas9 proteins, but reduce cell damage in long time incubation with the high expressions. After the short-time induction, the cultures were screened for the kan mutants on CTT agar plates using the kanamycin resistance. Interestingly, the transient high expressions of cas9 at the 200 μM copper concentration led to the deletion efficiency of the myxovirescin gene cluster by sgRNA-11-2 approaching to 15.3 ± 3% of the bacterial population (Fig. 5b). At the concentration of 200 μM copper, the deletion rates by sgRNA11-3, -4 also reached to 0.67 and 2.33%, respectively. However, in the case of sgRNA11-1, there was still no positive colony from the screening of 200 colonies after the transient induction at the concentration of 200 μM copper ion.

Optimization of 20 nt sgRNA spacers for the deletion of the myxalamid gene cluster

The above results not only indicated that temporally highly expressed cas9 gene promoted the deletion efficiency, but also that the sequence features of a 20-nt spacer markedly affected the deletion rate of large fragments. This phenomenon also occurred in other bacteria, for example, in the assays of sgRNA contributions to cleavage efficiency in the deletion of a gene in S. coelicolor, where the highest deletion rate (60%) of one spacer was approximately two times higher than that of the other two spacers [19]. In their studies, Huang et al. designed the three 20 nt spacers inside the 1-kb ORF. However, the four spacers from 11-1 to 11-4 were designed flanking the target biosynthetic gene cluster, with greatly varied distances to the left and right homologous arms (referred to Fig. 5a), which probably caused the markedly different cleavage efficiencies of these sgRNA. In addition, we compared parameters of the four spacers in the sgRNA sequences (sgRNA11-1 to sgRNA11-4) (Table 1). While the GC content of the 11-1 spacer sequence was 50%, the other three were 75%. All of these four spacers had no hairpin structure. Interestingly, the free energy changes of the four sgRNA spacers were in the same order of the cleavage efficiency, i.e. 11-2 > 11-4 > 11-3 > 11-1. The free energy changes were small between 11-2, 11-3 and 11-4 spacers, but their cleavage efficiency differences were significant (Fig. 5b).

Lots of 20 nt spacers have been evaluated of the nucleotide preference at each position in the sequence across bacteria to human cell lines. If P values of the non-preferred nucleotides were set to 0.05, we could summarize a degenerate optimal spacer sequence 5′NVH-N2-BNH-N2-H-N5-HHNB-TGG (H: A/T/C, V: G/A/C, B: G/T/C, N: any nucleotide; the C-terminus TGG is the PAM motif) from findings by Liu et al. in mouse cell line [24]. However, the degenerate spacer sequence was not always consistent with those reported efficient spacer sequences, for example, the results published by Doench et al. [53], from which an optimal 20 nt spacer sequence 5′-NND-N5-H-N4-HNHNVVD-VGG (D: G/A/T, the others are the same as the above) could be proposed by setting the P value of non-preferred nucleotides to <0.01. These two degenerate optimal spacer sequences were greatly different. In our four spacer sequences, the 11-2 and 11-4 spacers fitted the degenerate spacer from Liu et al. [24] best, and then 11-1, while the 11-3 spacer had the many disfavored nucleotides (Table 1). Notably, when analyzing the rationally designed spacer sequences [24], we found that the spacer sequences in the highly active sgRNAs also had high free energies. Accordingly, we suggested that, in addition to the features of nucleotide preference, which might be varied in different contexts, the free energy of a spacer sequence was a critical factor to affect the cleavage efficiency.

We employed the proposed principle of 20 nt spacer for the deletion of the myxalamids biosynthetic gene cluster. We used PAM-containing 5′actgg to search 23-nt sequence that fits the 5′NVH-N2-BNH-N2-H-N5-HHACTGG architecture, and revealed seven qualified 20 nt spacers from one strand in the targeted 92 kb fragment of the myxalamids biosynthetic gene cluster (Fig. 6a; Table 1). All these seven spacers completely fitted the degenerate sequence. However, the free energy of these spacers was ranged from −35.8 to −49.3 kcals/mol, and the 17-6 spacer, which targeted the polyketide synthase gene mxaC, had the highest free energy. Similarly, the GC contents of these spacers were also varied, ranging from 55 to 80%. Two spacers (17-6 and 17-8) formed hairpins in the seed sequence but with different free energies, 49.3 and 39.3 kcals/mol. According to the above proposed principles, we selected the 17-6 spacer sequence to construct the pBJ-17 plasmid, which was further transformed into the wild type strain DK1622, producing strain DkpBJ17. Using the above protocol, we successfully got five kan strains from 35 colonies, and the deletion rate in these five mutants was confirmed to be 100% by PCR and sequencing (Fig. 6b, c). No myxalamid was produced in the mutants (Fig. 6d). The deletion efficiency of the 92-kb biosynthetic gene cluster for myxalamids thus reached to 14.3% of the bacterial population.
Fig. 6

Large fragment deletion of the myxalamid biosynthetic gene cluster in M. xanthus DK1622 using the optimized spacer 17-6. a The seven sgRNA target sites (17-4 to 17-10) were revealed in or near the myxalamid gene cluster. The genes involved in the biosynthesis of myxalamid are shown in arrows. The positions of the guide sequence are indicated. b Identification of mutant strains by agarose gel electrophoresis of PCR product. The 4.0-kb positive fragment (shown with red arrow) appeared in different mutants (1–16), but not in DK1622 (c). c Chromatograms of the 4.0-kb PCR product DNA sequences, sequenced using the PCR primers as the sequencing primers. d EIC of myxalamid A ([M+H]+ m/z 416.31) from DK1622 (red) and mutant (blue)

Effects of the deletion of genes for secondary metabolites on the yields of others

In M. xanthus DK1622, there are 24 gene clusters for the biosynthesis of secondary metabolites, and six compounds have been identified and correlated to their gene clusters (Additional file 4: Figure S4). Most of these 24 gene clusters are of polyketide synthase (PKS) and/or nonribosomal peptide synthetase (NRPS), which are suggested to be interrelated because of complex regulation network, similar substrate units and transportation. To investigate effects of the deletions on the biosyntheses of other secondary metabolites, we compared the relative productions of some known secondary metabolites, i.e. myxalamids, myxovirescin (TA), myxoprincomide and DKxanthenes [48] in M. xanthus DK1622 and the deletion mutants of myxalamid or myxovirescin genes based on the LC–MS semiquantitative analysis. To avoid the influence from cultivation, we selected the yield of DKxanthene 534 as the standard to estimate ratio changes of the metabolites in the same strain.

Among the analyzed compounds, myxalamid A had the largest yield in DK1622, reaching 1.5 times of DKxanthene 534, while myxoprincomide had a similar yield as DKxanthene 534, but myxovirescin gave the lowest yield, approximately one-third of DKxanthene 534 (Fig. 7a). The productions of DKxanthene 534 and myxalamid A homologues were greatly higher than their homologues, which were similar to the production of myxovirescin. In the myxalamid-deleted mutant (DK-dMA17), the yield ratio between myxoprincomide and DKxanthene 534 was almost unchanged, but the ratio between myxovirescin and DKxanthene 534 greatly increased to approximately 6.4-folds of the ratio in the wild type strain (Fig. 7a). After the deletion of myxovirescin, the yield ratio between DKxanthene 534 and myxalamid A was almost unchanged in the mutant DK-dMV11, but the yield of myxoprincomide became approximately one-third of DKxanthene 534. Notably, the ratios between the homologues of myxalamid or DKxanthene were almost unchanged in the mutants.
Fig. 7

Comparison of the yields of secondary metabolites in M. xanthus DK1622 and epothilone-producing mutant with the deletion of myxalamid or myxovirescin genes. a In each single strain, the yield of DKxanthene 534 was set as standard, and the ratios of the yields of other metabolites were provided. Experiments were performed in triplicate. Error bars indicate standard deviations. DK-dMA17, the myxalamid-deleted mutant from DK1622; DK-dMV11, the myxovirescin-deleted mutant from DK1622; KE10dD-MV, the myxovirescin-deleted mutant from the epothilone-producing strain KE10. b EIC of myxovirescin A ([M+H]+ m/z 624.44, red) and epothilone B ([M+H]+ m/z 508.27, green) in KE10Dp11t. c EIC of myxovirescin A ([M+H]+ m/z 624.44, red) and epothilone B ([M+H]+ m/z 508.27, green) from KE10dD-MV. d The fragmentation patterns of epothilone B produced in the KE10Dp11t and KE10dD-MV with the correct molecular weight minus the H+, Na+, K+ (epothilone B = 507)

In our previous studies, we integrated the 56-kb gene cluster for the biosynthesis of antitumor polyketides epothilones into M. xanthus genome by transposition techniques [34]. To study effects of the deletion of endogenous biosynthetic gene cluster for secondary metabolites on the production of epothilones, we employed an epothilone-producing M. xanthus strain KE10 (Additional file 4: Figure S4) for the deletion of the myxovirescin gene cluster using a similar process based on pSWU30EE-2. Before the deletion, the resistance genes that were introduced into the genome accompanying with the epothilone gene cluster were removed from the epothilone-producing strain KE10 to obtain strain KE10D (Additional file 5: Figure S5). The pBJ-11 plasmid was further integrated into the genome of KE10D by the long right arm (1953 bp) to give the strain KE10Dp11. Then, the cas9/sgRNA-11 expression plasmid pSWU30EE-2-112 was integrated into the genome, producing the strain KE10Dp11t. The KE10Dp11t strain was still able to yield the major epothilone B analogue (Fig. 7b), and the yield of epothilone B was determined using HPLC–MS (Fig. 7c). After the induction by copper ion and the selection of kanamycin for KE10Dp11t using the above optimized method, we got the myxovirescin-deleted epothilone-producing strain KE10dD-MV (Fig. 7d) at about 8% of the bacterial population, a slightly less efficiency than that obtained in wild type DK1622. Like in the wild type strain DK1622, the deletion rate was 100% in the epothilone-producing M. xanthus strain. The correctness of kanamycin-negative colonies was confirmed by PCR and sequencing. From the ratios shown in Fig. 7a, the yield of epothilone B only occupied a small part of the repertoire of the secondary metabolites producible in the epothilone-producing M. xanthus cells. Notably, the relative yields of metabolites compared with DKxanthene 534 were mostly lower in KE10dD-MV than that in DK1622. However, compared with that in DK-dMV11, the myxovirescin-deletion epothilone-producer had lower yields of myxalamids, but higher yield of myxoprincomide (Fig. 7a). The above results showed that the deletion of biosynthetic gene clusters for secondary metabolites was able to significantly change the production of some other secondary metabolites in M. xanthus.

Discussion

The researches on myxobacterial natural products gain great attentions [40, 4951], but are normally limited by long generation time and laborious performances in cultivation and genetics. Compared with other ‘microbial factories’ like S. coelicolor or E. coli, the genetic manipulation methods available in M. xanthus are limited and normally laborious. In this study, we established an efficient CRISPR/Cas9 system for the deletion of large genome fragments in M. xanthus DK1622 after resolving some critical limits. For example, we employed pBJ113 to delete the 8.4-kb resistance-related genes that were introduced into the genome accompanying with the epothilone gene cluster (Additional file 5: Figure S5). After the kanamycin and galactose selections, we obtained strain KE10D with a deletion efficiency of 3.7%, which required lots of PCR to identify the recovery mutant. Comparatively, the recovered kanamycin resistant mutants by the proposed CRISPR/Cas9 deletion protocol were all the deletion mutants. In this protocol, we developed a strategy for temporally high expressions of Cas9 to decrease cytotoxicity of the endonuclease in M. xanthus, and optimized the deletion protocol by using a tRNA–sgRNA–tRNA strategy to ensure the correct targeting by sgRNA sequence. We found that the free energy of a 20 nt spacer sequence was positively correlated with the Cas9 cleavage efficiency. Because Cas9 has no energy-dependent helicase activity, the mechanism of the local DNA unwinding is still unknown, but probably relies upon thermally available energy [52]. We speculated that higher free energy of 20 nt spacer might help the formation of the RNA:DNA heteroduplex. Cas9 is not converted into a more active conformation for executing its nuclease function, but instead, the generated RNA:DNA heteroduplex might provide substrates for a more efficient activity nuclease activity of Cas9.

In theory, any specific 20 nt sequence followed by a PAM can be used to target the DNA sequence for the Cas9-induced directed cleavage, but the cleavage efficiencies of different spacers may be varied. There are three sequence features affecting the efficiency of 20 nt spacer, i.e. the GC content, secondary structure and nucleotide preference. Analysis of these sequence features, however, produced opposite conclusions. For example, the GC content within the range of 40–60% was proposed to be favored based on investigations in eukaryotic cells for a high gRNA activity [22, 24, 25, 46, 53, 54]. However, the studies in zebrafish embryos observed a positive correlation between GC content and indel frequency that was produced by the Cas9 cleavage via nonhomologous end joining repair system [23]. Thyme et al. comprehensively analyzed effects of intra-sgRNA interactions on cleavage efficiency, and proposed the presence of a hairpin structure inhibited cleavage [10]. In contrast, Liu et al. proposed that if the seed sequence is more likely to form secondary structure, the sgRNA has a higher chance of cleaving the target sequence [24]. The 8–12 PAM-proximal bases, namely the seed sequence of sgRNA, were proposed to be more important than the other spacer bases in the determination of targeting specificity [13, 22, 46, 53, 54]. However, from the evaluation of the cleavage activities of 218 sgRNAs using in vitro Surveyor assays in mouse cell line, Takummi and collaborators found that the nucleotides at either PAM-distal or PAM-proximal regions of spacer were significantly correlated with the on-target efficiency [24]. This is in line with the observation found in zebrafish that the PAM-distal sequences were involved in targeting cleavage and that the Cas9-target binding depended on the PAM-proximal sequences [55]. Liu et al. reported that the nucleotides at positions 2(T), 3(G), 6(A), 8(G), 11(G), 17(G), 18(G) and 20(A) were disfavored for cleavage activity based on their in vitro mismatch nuclease assay in mouse cells [24]. However, by investigating nucleotide preference at each position of the 20 nt spacer sequence and PAM in 1841 sgRNAs, Doench et al. found that the nucleotides at positions 3(C), 9(G), 14(G), 16(G), 18(T), 19(T) and 20(C) were disfavored [50]. The activity measurement of 1280 sgRNAs targeting 128 different genes in the zebrafish genome showed that the guanine enrichment and the adenine depletion increased sgRNA stability and activity [25], which were different from the above results of the disfavored nucleotides in 20 nt spacer sequences. Similarly, Gagnon et al. observed that G is favored, and A is disfavored in the 20th position [23]. Accordingly, from references, as well as from our results, different 20 nt spacer sequences significantly affect the Cas9 cleavage efficiency, probably depending on the editing genomes or experimental conditions. Herein, the free energy of spacer sequence plays a critical role.

In this study, we proposed a degenerate sequence for the design of an optimal 20 nt spacer from the evaluation of 20 nt spacer sequences and their cleavage efficiencies in references related to Streptomyces [19], mouse cell line [24] and human cell lines [7]. Our experimental results showed that the spacer formula was consistent with the finding of position-dependent nucleotide features of 20 nt spacer published by Huang et al. [16, 17], and was similar to the results obtained from the in vitro results of mouse cell line, if P values of non-preferred nucleotides were set to <0.05 [24]. This optimal degenerate sequence fits many efficient Cas9-induced DNA cleavage from bacteria to human. We suggested that the findings and proposals described in this paper were workable in different organisms, at least the Gram negative bacteria with high GC content.

Methods

Strains, media and reagents

Strains and plasmids are listed in Additional file 6: Table S1. Escherichia coli strain Top 10, used for plasmid cloning and maintenance, was grown in LB medium supplemented with tetracycline (5 µg/mL) and kanamycin (20 µg/mL) when needed. Myxococcus xanthus DK1622 and its mutant strains were grown in CTT medium with kanamycin (40 µg/mL) and/or Tetracycline (15 µg/mL) if needed.

The oligonucleotide primers used in this study (Additional file 7: Table S2) were synthesized by Sangon (Shanghai, China). KOD plus Neo DNA polymerase (Toyobo, Osaka, Japan) was used for high fidelity PCR amplification. Restriction digestion enzymes and ligase were purchased from Thermo Fisher Scientific (USA)and Takara (Dalian, China).

Construction of plasmids

We designed a tRNA–sgRNA–tRNA chimeric gene for correct production of sgRNA using the previously described method [12] with modifications. This chimeric gene was under the control of the T7A1 constitutive promoter (Accession no. A15404) or pilA promoter (the complement sequence 7159461..7159631 in M. xanthus DK1622), along with the widely-used T7 terminator (Additional file 1: Figure S1). There are five Gly-tRNA genes in DK1622, and we selected the MXAN_3066 gene (corresponding to the GGA codon) to integrate into the cassette. The tRNA–sgRNA–tRNA expression cassette following the promoter T7A1 was synthesized by Sangon Company (Shanghai, China) and cloned into the pUC57 vector to give the plasmid pUC57-TXX (Additional file 2: Figure S2). Golden Gate assembly was employed to substitute the T7A1 promoter to the pilA promoter, which was obtained by PCR amplification from the DK1622 genome, to produce the plasmid pUC-PXX (Additional file 2: Figure S2). This small circular pUC57-sgRNA (pUC-TXX or pUC-PXX) was used as a template for PCR amplification with the primer pair gScaff-F/gRNAX-R containing a 20-nt target spacer by KOD-Plus-Neo high fidelity DNA polymerase (Fig. 3b). After phosphorylation and self-ligation circularization of PCR fragment, we obtained plasmids with the tRNA–sgRNA–tRNA cassette targeting different sites. Then we cloned these cassettes into pSWU30EE series plasmids by double digestion with EcoRI and HindIII (Additional file 3: Figure S3).

The codon-optimized cas9 gene was obtained by double digestion of plasmid pKCcas9d 6424 [19] with NdeI and EcoRI, and then ligated into pET28a digested with NdeI and EcoRI to yield pET28a–cas9 (Additional file 3: Figure S3). The constitutive PpilA174 promoter (the complementary sequence 7159458..7159631 in DK1622 genome; we added an additional ATG before the cas9 gene) and the copper-inducible PcuoA promoter (the complementary sequence 3976002..3976945 in DK1622 genome) were obtained from M. xanthus DK1622 using the primers PcuF4/PcuR4 and PilAF/PilAR, respectively. These two fragments were digested with XbaI and NdeI, and then ligated into pET28a–cas9 to produce plasmids pET28a–PpilA174-cas9 and pET28a–PcuoA-cas9, respectively. Finally, the vector pSWU30 was changed to pSWU30E at the EcoRI site, producing the pSWU30EE-1,-2,-3 plasmids.

To construct plasmids with homologous arms, pBJ113 was used by conventional cloning method with three restriction enzymes of EcoRI, XbaI and HindIII. To increase the homologous recombination efficiency, the length of homologous arms was designed to be 1.5–2.0 kb. To construct the plasmid pBJ11, the primer pair of S11U-1483F and S11U-2619R was used to amplify the left homologous arm, which was then digested by EcoRI + XbaI and ligated to vector pBJ113 to give plasmid pBJ113-11U. The primer pair of S11D-141F and S11D-2093R was used to amplify the right homologous arm, which was digested by XbaI + HindIII and ligated to pBJ113-11U to give plasmid pBJ11. By the same method, we constructed plasmid pBJ17.

The above plasmid constructions were confirmed by restriction analysis and sequencing.

Electro-transformation of M. xanthus

Homologous recombination plasmid pBJ113 series and cas9 expression plasmid pSWU30EE series were stepwise electro-transformed into M. xanthus cells. The constructed plasmids were introduced into M. xanthus cells using electroporation as described previously [56] with small modifications. We firstly integrated the pBJ113 series plasmids into DK1622 genome by homologous recombination. The pBJ113 series plasmids containing two homologous arms located at the both ends of a selected large gene cluster were electro-incorporated into DK1622, and then resistant mutants were screened on CTT+kan agar plate. After confirmation of integration type (left or right homologous arm) by PCR amplification, we then integrated the pSWU30EE series plasmids into genome by site-specific recombination. The PpilA-driven pSWU30EE-1 or PcuoA-driven pSWU30EE-2, -3 plasmids were transferred into kanamycin-positive mutant strains. The transformants were screened on CTT+Kan+Tet agar plate. After 4–5 days of incubation at 30 °C, we transferred the resistant strains into fresh CTT liquid medium.

Induction of cas9 expression by copper ion

Double integrated mutants were grown on agar plate containing CTT+Kan+Tet medium without copper for 3–4 days. Then the cells were transferred into a fresh CTT liquid medium supplemented with 25 μM concentration of copper, and adjusted to an optical density of 0.05 at 600 nm (OD600). After 48 h of incubation at 30 °C (before reaching the end of logarithmic phase), the cells were harvested and mixed in soft agar, spread on CTT agar plates to screen the survival colonies.

Induction of temporally high expression was performed as below. The mutants were cultivated in CTT+Kan+Tet medium without copper for 48 h at 30 °C. The cells were harvested by centrifugation, washed one time with fresh liquid CTT medium, and then inoculated into fresh liquid CTT medium supplemented with the copper concentrations needed. After approximately 4 h of incubation (one generation time) at 30 °C, the cells were mixed in soft agar for plating on CTT agar plates.

Screening of the deletion mutants by kanamycin selection and PCR sequencing

After induction by copper ion, the cells were spread on CTT agar plates, and incubated for 5–7 days. The single colonies were transferred simultaneously to new CTT agar plates supplemented with and without kanamycin. Normally, 100 or 200 colonies were transferred for the screening. The percentage of the colonies that were unable to grow on CTT+kan agar plate in the total colonies on CTT plates were calculated as the cleavage efficiency. The kan colonies were further determined by PCR amplification and sequencing for the deletion of the genome fragments.

Preparation of M. xanthus sample sets for the assay of secondary metabolites

Myxococcus xanthus strains were cultivated in 50-mL CTT medium supplemented with 2% XAD-16 resin (Sigma-Aldrich). After 96 h of shaking at 200 rpm and 30 °C, the cells and XAD resin were harvested by centrifugation (20 min, 5000 rpm, 20 °C). The pellet was extracted with 3 mL methanol overnight, and the extracts were dried in vacuum and resuspended in 3 mL distilled methanol. Three replicates were performed for each experiment.

Identification of compounds using high-resolution HPLC–MS/MS system

HPLC–MS/MS was performed on a rapid separation liquid chromatography system (Dionex, UltiMate3000, UHPLC) coupled with an ESI-Q-TOF mass spectrometer (Bruker Daltonics, Impact HD). Separation of compounds was performed on an YMC-Packpro C18 column (250 mm × 4.6 mm I.D., particle size 5 µm) with mobile phase system of 0.1% formic acid (Sigma) in Mili-Q filtered water (A) and 0.1% formic acid (Sigma) in acetonitrile (Fisher Scientific) (B). The following gradient program was applied at a flow rate of 0.75 mL/min: 0–5 min 95% A + 5% B; 5–45 min 95–5% A + 5–95% B; 45–60 min 5% A + 95% B.

The MS/MS analysis was performed by otofControl software (Bruker Daltonics) under the following conditions: ESI-positive mode for scanning, enhanced quadratic mode for calibration, nebulizer gas nitrogen with 1 bar, dry gas nitrogen with 8 L/min, probe temperature of 180 °C, full scan mass range from 50 to 1500 m/z, auto MS/MS for each precursor ion. The individual extraction chromatograms and their abundances in area were confirmed by the formulas, m/z values and MS/MS fragments information using DataAnalysis software (Bruker Daltonics). The production levels of compounds were averaged from three independent cultivations and extractions.

Declarations

Authors’ contributions

YYJ, ZFL and YZL designed the experiments. YYJ, YW, YG, PZ and WCH performed the experiments. YYJ, YW, DHS and YZL analyzed the data. YYJ and YZL wrote the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We thank José Muñoz-Dorado and Yinhua Lu for providing plasmids.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

All data generated or analyzed during this study are included in this published article and in its Additional files.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Funding

This work was financially supported by the National Natural Science Foundation of China (NSFC) (Nos. 31471183 and 31670076) and the Key Program of Shandong Natural Science Foundation (No. ZR2016QZ002) to YZL, and NSFC (No. 31370123) to ZFL.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
State Key Laboratory of Microbial Technology, School of Life Science, Shandong University

References

  1. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P. CRISPR provides acquired resistance against viruses in prokaryotes. Science. 2007;315:1709–12.View ArticleGoogle Scholar
  2. Brouns SJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJ, Snijders AP, Dickman MJ, Makarova KS, Koonin EV, van der Oost J. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science. 2008;321:960–4.View ArticleGoogle Scholar
  3. Marraffini LA, Sontheimer EJ. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science. 2008;322:1843–5.View ArticleGoogle Scholar
  4. Sapranauskas R, Gasiunas G, Fremaux C, Barrangou R, Horvath P, Siksnys V. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res. 2011;39:9275–82.View ArticleGoogle Scholar
  5. Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Eckert MR, Vogel J, Charpentier E. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature. 2011;471:602–7.View ArticleGoogle Scholar
  6. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337:816–21.View ArticleGoogle Scholar
  7. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. RNA-guided human genome engineering via Cas9. Science. 2013;339:823–6.View ArticleGoogle Scholar
  8. Pohl C, Kiel JA, Driessen AJ, Bovenberg RA, Nygard Y. CRISPR/Cas9 based genome editing of Penicillium chrysogenum. ACS Synth Biol. 2016;5:754–64.View ArticleGoogle Scholar
  9. Shi S, Liang Y, Zhang MM, Ang EL, Zhao H. A highly efficient single-step, markerless strategy for multi-copy chromosomal integration of large biochemical pathways in Saccharomyces cerevisiae. Metab Eng. 2016;33:19–27.View ArticleGoogle Scholar
  10. Thyme SB, Akhmetova L, Montague TG, Valen E, Schier AF. Internal guide RNA interactions interfere with Cas9-mediated cleavage. Nat Commun. 2016;7:11750.View ArticleGoogle Scholar
  11. Zhang L, Reed RD. Genome editing in butterflies reveals that spalt promotes and distal-less represses eyespot colour patterns. Nat Commun. 2016;7:11769.View ArticleGoogle Scholar
  12. Xie K, Minkenberg B, Yang Y. Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system. Proc Natl Acad Sci USA. 2015;112:3570–5.View ArticleGoogle Scholar
  13. Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA. RNA-guided editing of bacterial genomes using CRISPR–Cas systems. Nat Biotechnol. 2013;31:233–9.View ArticleGoogle Scholar
  14. Zhang K, Duan X, Wu J. Multigene disruption in undomesticated Bacillus subtilis ATCC 6051a using the CRISPR/Cas9 system. Sci Rep. 2016;6:27943.View ArticleGoogle Scholar
  15. Cleto S, Jensen JV, Wendisch VF, Lu TK. Corynebacterium glutamicum metabolic engineering with CRISPR interference (CRISPRi). ACS Synth Biol. 2016;5:375–85.View ArticleGoogle Scholar
  16. Huang H, Chai C, Li N, Rowe P, Minton NP, Yang S, Jiang W, Gu Y. CRISPR/Cas9-based efficient genome editing in Clostridium ljungdahlii, an autotrophic gas-fermenting bacterium. ACS Synth Biol. 2016;5:1355–61.View ArticleGoogle Scholar
  17. Wang Y, Zhang ZT, Seo SO, Lynn P, Lu T, Jin YS, Blaschek HP. Bacterial genome editing with CRISPR–Cas9: deletion, integration, single nucleotide modification, and desirable “clean” mutant selection in Clostridium beijerinckii as an example. ACS Synth Biol. 2016;5:721–32.View ArticleGoogle Scholar
  18. Oh JH, van Pijkeren JP. CRISPR–Cas9-assisted recombineering in Lactobacillus reuteri. Nucleic Acids Res. 2014;42:e131.View ArticleGoogle Scholar
  19. Huang H, Zheng G, Jiang W, Hu H, Lu Y. One-step high-efficiency CRISPR/Cas9-mediated genome editing in Streptomyces. Acta Biochim Biophys Sin (Shanghai). 2015;47:231–43.View ArticleGoogle Scholar
  20. Cobb RE, Wang Y, Zhao H. High-efficiency multiplex genome editing of Streptomyces species using an engineered CRISPR/Cas system. ACS Synth Biol. 2015;4:723–8.View ArticleGoogle Scholar
  21. Zeng H, Wen S, Xu W, He Z, Zhai G, Liu Y, Deng Z, Sun Y. Highly efficient editing of the actinorhodin polyketide chain length factor gene in Streptomyces coelicolor M145 using CRISPR/Cas9-CodA(sm) combined system. Appl Microbiol Biotechnol. 2015;99:10575–85.View ArticleGoogle Scholar
  22. Xu H, Xiao T, Chen CH, Li W, Meyer CA, Wu Q, Wu D, Cong L, Zhang F, Liu JS, et al. Sequence determinants of improved CRISPR sgRNA design. Genome Res. 2015;25:1147–57.View ArticleGoogle Scholar
  23. Gagnon JA, Valen E, Thyme SB, Huang P, Akhmetova L, Pauli A, Montague TG, Zimmerman S, Richter C, Schier AF. Efficient mutagenesis by Cas9 protein-mediated oligonucleotide insertion and large-scale assessment of single-guide RNAs. PLoS ONE. 2014;9:e98186.View ArticleGoogle Scholar
  24. Liu X, Homma A, Sayadi J, Yang S, Ohashi J, Takumi T. Sequence features associated with the cleavage efficiency of CRISPR/Cas9 system. Sci Rep. 2016;6:19675.View ArticleGoogle Scholar
  25. Moreno-Mateos MA, Vejnar CE, Beaudoin J-D, Fernandez JP, Mis EK, Khokha MK, Giraldez AJ. CRISPRscan: designing highly efficient sgRNAs for CRISPR–Cas9 targeting in vivo. Nat Methods. 2015;12:982–8.View ArticleGoogle Scholar
  26. Reichenbach H. Myxobacteria, producers of novel bioactive substances. J Ind Microbiol Biotechnol. 2001;27:149–56.View ArticleGoogle Scholar
  27. Kaiser D, Robinson M, Kroos L. Myxobacteria, polarity, and multicellular morphogenesis. Cold Spring Harb Perspect Biol. 2010;2:a000380.View ArticleGoogle Scholar
  28. Munoz-Dorado J, Marcos-Torres FJ, Garcia-Bravo E, Moraleda-Munoz A, Perez J. Myxobacteria: moving, Killing, feeding, and surviving together. Front Microbiol. 2016;7:781.View ArticleGoogle Scholar
  29. Li ZF, Li X, Liu H, Liu X, Han K, Wu ZH, Hu W, Li FF, Li YZ. Genome sequence of the halotolerant marine bacterium Myxococcus fulvus HW-1. J Bacteriol. 2011;193:5015–6.View ArticleGoogle Scholar
  30. Goldman BS, Nierman WC, Kaiser D, Slater SC, Durkin AS, Eisen JA, Ronning CM, Barbazuk WB, Blanchard M, Field C, et al. Evolution of sensory complexity recorded in a myxobacterial genome. Proc Natl Acad Sci USA. 2006;103:15200–5.View ArticleGoogle Scholar
  31. Muller S, Willett JW, Bahr SM, Darnell CL, Hummels KR, Dong CK, Vlamakis HC, Kirby JR. Draft genome sequence of Myxococcus xanthus wild-type strain DZ2, a model organism for predation and development. Genome Announc. 2013;1:e00217.Google Scholar
  32. Chen XJ, Han K, Feng J, Zhuo L, Li YJ, Li YZ. The complete genome sequence and analysis of a plasmid-bearing myxobacterial strain Myxococcus fulvus 124B02 (M 206081). Stand Genom Sci. 2016;11:1.View ArticleGoogle Scholar
  33. Fu J, Wenzel SC, Perlova O, Wang J, Gross F, Tang Z, Yin Y, Stewart AF, Muller R, Zhang Y. Efficient transfer of two large secondary metabolite pathway gene clusters into heterologous hosts by transposition. Nucleic Acids Res. 2008;36:e113.View ArticleGoogle Scholar
  34. Zhu LP, Yue XJ, Han K, Li ZF, Zheng LS, Yi XN, Wang HL, Zhang YM, Li YZ. Allopatric integrations selectively change host transcriptomes, leading to varied expression efficiencies of exotic genes in Myxococcus xanthus. Microb Cell Fact. 2015;14:105.View ArticleGoogle Scholar
  35. Sun Y, Feng Z, Tomura T, Suzuki A, Miyano S, Tsuge T, Mori H, Suh JW, Iizuka T, Fudou R, Ojika M. Heterologous production of the marine myxobacterial antibiotic haliangicin and Its unnatural analogues generated by engineering of the biochemical pathway. Sci Rep. 2016;6:22091.View ArticleGoogle Scholar
  36. Tu Q, Herrmann J, Hu S, Raju R, Bian X, Zhang Y, Muller R. Genetic engineering and heterologous expression of the disorazol biosynthetic gene cluster via Red/ET recombineering. Sci Rep. 2016;6:21066.View ArticleGoogle Scholar
  37. Stevens DC, Henry MR, Murphy KA, Boddy CN. Heterologous expression of the oxytetracycline biosynthetic pathway in Myxococcus xanthus. Appl Environ Microbiol. 2010;76:2681–3.View ArticleGoogle Scholar
  38. Weber T, Blin K, Duddela S, Krug D, Kim HU, Bruccoleri R, Lee SY, Fischbach MA, Muller R, Wohlleben W, et al. antiSMASH 3.0-a comprehensive resource for the genome mining of biosynthetic gene clusters. Nucleic Acids Res. 2015;43:W237–43.View ArticleGoogle Scholar
  39. Bode HB, Meiser P, Klefisch T, Cortina NS, Krug D, Gohring A, Schwar G, Mahmud T, Elnakady YA, Muller R. Mutasynthesis-derived myxalamids and origin of the isobutyryl-CoA starter unit of myxalamid B. ChemBioChem. 2007;8:2139–44.View ArticleGoogle Scholar
  40. Bode HB, Muller R. The impact of bacterial genomics on natural product research. Angew Chem Int Ed Engl. 2005;44:6828–46.View ArticleGoogle Scholar
  41. Wenzel SC, Meiser P, Binz TM, Mahmud T, Muller R. Nonribosomal peptide biosynthesis: point mutations and module skipping lead to chemical diversity. Angew Chem Int Ed Engl. 2006;45:2296–301.View ArticleGoogle Scholar
  42. Simunovic V, Zapp J, Rachid S, Krug D, Meiser P, Muller R. Myxovirescin A biosynthesis is directed by hybrid polyketide synthases/nonribosomal peptide synthetase, 3-hydroxy-3-methylglutaryl-CoA synthases, and trans-acting acyltransferases. ChemBioChem. 2006;7:1206–20.View ArticleGoogle Scholar
  43. Schley C, Altmeyer MO, Swart R, Müller R, Huber CG. Proteome analysis of Myxococcus x anthus by off-line two-dimensional chromatographic separation Using monolithic poly-(styrene-divinylbenzene) columns combined with ion-trap tandem mass spectrometry. J Proteome Res. 2006;5:2760–8.View ArticleGoogle Scholar
  44. Wenzel SC, Müller R. Myxobacteria–’microbial factories’ for the production of bioactive secondary metabolites. Mol BioSyst. 2009;5:567–74.View ArticleGoogle Scholar
  45. Gomez-Santos N, Treuner-Lange A, Moraleda-Munoz A, Garcia-Bravo E, Garcia-Hernandez R, Martinez-Cayuela M, Perez J, Sogaard-Andersen L, Munoz-Dorado J. Comprehensive set of integrative plasmid vectors for copper-inducible gene expression in Myxococcus xanthus. Appl Environ Microbiol. 2012;78:2515–21.View ArticleGoogle Scholar
  46. Ren X, Yang Z, Xu J, Sun J, Mao D, Hu Y, Yang SJ, Qiao HH, Wang X, Hu Q, et al. Enhanced specificity and efficiency of the CRISPR/Cas9 system with optimized sgRNA parameters in Drosophila. Cell Rep. 2014;9:1151–62.View ArticleGoogle Scholar
  47. Engler C, Kandzia R, Marillonnet S. A one pot, one step, precision cloning method with high throughput capability. PLoS ONE. 2008;3:e3647.View ArticleGoogle Scholar
  48. Krug D, Zurek G, Revermann O, Vos M, Velicer GJ, Muller R. Discovering the hidden secondary metabolome of Myxococcus xanthus: a study of intraspecific diversity. Appl Environ Microbiol. 2008;74:3058–68.View ArticleGoogle Scholar
  49. Wenzel SC, Muller R. Recent developments towards the heterologous expression of complex bacterial natural product biosynthetic pathways. Curr Opin Biotechnol. 2005;16:594–606.View ArticleGoogle Scholar
  50. Muller R, Wink J. Future potential for anti-infectives from bacteria—how to exploit biodiversity and genomic potential. Int J Med Microbiol. 2014;304:3–13.View ArticleGoogle Scholar
  51. Landwehr W, Wolf C, Wink J. Actinobacteria and Myxobacteria-two of the most important bacterial resources for novel antibiotics. Curr Top Microbiol Immunol. 2016;398:273–302.Google Scholar
  52. Sternberg SH, Redding S, Jinek M, Greene EC, Doudna JA. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature. 2014;507:62–7.View ArticleGoogle Scholar
  53. Doench JG, Hartenian E, Graham DB, Tothova Z, Hegde M, Smith I, Sullender M, Ebert BL, Xavier RJ, Root DE. Rational design of highly active sgRNAs for CRISPR–Cas9-mediated gene inactivation. Nat Biotechnol. 2014;32:1262–7.View ArticleGoogle Scholar
  54. Wang T, Wei JJ, Sabatini DM, Lander ES. Genetic screens in human cells using the CRISPR–Cas9 system. Science. 2014;343:80–4.View ArticleGoogle Scholar
  55. Cencic R, Miura H, Malina A, Robert F, Ethier S, Schmeing TM, Dostie J, Pelletier J. Protospacer adjacent motif (PAM)-distal sequences engage CRISPR Cas9 DNA target cleavage. PLoS ONE. 2014;9:e109213.View ArticleGoogle Scholar
  56. Kuspa A, Kaiser D. Genes required for developmental signalling in Myxococcus xanthus: three asg loci. J Bacteriol. 1989;171:2762–72.View ArticleGoogle Scholar

Copyright

© The Author(s) 2017

Advertisement